Print this page
Translational Research on Integrated Predictive Liquid and Excretory biomarkers in Urothelial Carcinoma (TRIPLE-UC)
Our primary objectives are to:
1) identify genomic and microbiome related changes that can predict response to treatment therapies.
2) evaluate the effectiveness of monitoring changes in the microenvironment, alongside patient-specific genomic alterations, as predictors of long-term oncologic outcomes, including overall survival, recurrence-free survival, and disease-free survival.
3) assess the utility of monitoring changes in the microenvironment over time to determine differences among patients with and without postoperative complications.
Protocol Number:
082412
Phase:
N/A
Applicable Disease Sites:
Urinary Bladder
Principal Investigator:
Saum Ghodoussipour
Scope:
Local
Participating Institutions:
- Rutgers University
For further information about clinical trials, please contact us at 732-235-7356.